Role of RT-PCR tyrosinase detection in the monitoring of patients with advanced metastatic melanoma

Melanoma Research

Volumn 10, Issue 6, 2000, Pages 545-555

  Abate, S O ^a   Savoia, P ^a   Cambieri, I ^a   Salomone, B ^a   Quaglino, P ^a   Bernengo, M G ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Circulating melanoma cells; Metastatic melanoma; RT PCR; Tyrosinase

Indexed keywords

MONOPHENOL MONOOXYGENASE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD SAMPLING; CANCER SURVIVAL; DISEASE COURSE; EARLY DIAGNOSIS; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; MESSENGER RNA SYNTHESIS; METASTASIS POTENTIAL; MONITORING; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; BRAIN NEOPLASMS; DNA; DNA, COMPLEMENTARY; FEMALE; HUMANS; KIDNEY NEOPLASMS; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MELANINS; MELANOMA; MIDDLE AGED; MONOPHENOL MONOOXYGENASE; NEOPLASM CIRCULATING CELLS; NEOPLASM METASTASIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS;

EID: 0034532543     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200012000-00006     Document Type: Article

References (34)

1. Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thickness
2. The heart in malignant melanoma: A study of 70 autopsy cases
3. Cardiac metastases
4. Late recurrence of malignant melanoma: Analysis of 186 patients
5. Late recurrence of malignant melanoma: A report of five cases, a review of the literature and a study of associated factors
6. Ultra-late recurrence (15 years or longer) of cutaneous melanoma
7. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction
8. An improved and combined reverse transcription-polymerase chain reaction assay for reliable detection of metastatic melanoma cells in peripheral blood
9. Analysis of mammalian pigmentation at the molecular level
10. Tyrosinase gene expression in human tissues
11. Detection of circulating melanoma cells by specific amplification of tyrosinase complementary DNA is not a reliable tumor marker in melanoma patients: A clinical two-center study
12. Polymerase chain reaction detection of melanoma cells in the circulation: Relation to clinical stage, surgical treatment and recurrence from melanoma
13. Prognostic significance of peripheral blood and bone marrow tyrosinase messenger RNA in malignant melanoma
14. Hematogenous spread of malignant melanoma cells in different stages of disease
15. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay
16. A polymerase chain reaction-based semiquantitative assessment of malignant melanoma cells in peripheral blood
17. Reporting results of cancer treatment
18. Butyric acid effects on melanoma cell lines: Apoptosis induction and cell cycle cytofluorimetric evaluation
19. Detection of circulating neoplastic cells by reversetranscriptase polymerase chain reaction in malignant melanoma: Association with clinical stage and prognosis
20. Polymerase chain reaction detection of circulating melanocytes as a prognostic marker in patient with melanoma
21. The detection of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction
22. Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma
23. Reverse transcriptase-polymerase chain reaction for the expression of tyrosinase to identify malignant melanoma cells in peripheral blood
24. Immunophenotyping of melanomas for tyrosinase: Implications for vaccine development
25. Detection of tyrosinase mRNA by RT-PCR in the peripheral blood of patients with advanced metastatic melanoma
26. Jr, Seigler HE Recurrent malignant melanoma: The identification of prognostic factors to predict survival
27. RT-PCR for tyrosinase-mRNApositive cells in peripheral blood: Evaluation strategy and correlation with known prognostic markers in 123 melanoma patients
28. Treatment of metastatic melanoma with combined chemotherapy containing cisplatin, vinblastine and dacarbazine (CVD) and biotherapy using interleukin-2 and interferon-alpha
29. Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and intefieuldn-2 for patients with metastatic melanoma
30. Combination chemotherapy in metastatic malignant melanoma: A randomized study of three DTIC-containing combinations
31. Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma
32. Low dose integrated chemo-immuno-hormonotherapy with cisplatin, subcutaneous interleukin-2, alpha interferon and tamoxifen for advanced metastatic melanoma: A pilot study
33. Combination chemotherapy with cisplatin, carmustine, dacarbazine and tamoxifen in metastatic melanoma